{
    "clinical_study": {
        "@rank": "33491", 
        "arm_group": {
            "arm_group_label": "ENTegral Artificial Larynx implant", 
            "arm_group_type": "Experimental", 
            "description": "ENTegral Artificial Larynx implantation"
        }, 
        "brief_summary": {
            "textblock": "The objective of this clinical study is to evaluate the feasibility, safety and efficacy of\n      the ENTegral Artificial Larynx (AL) in patients indicated for total laryngectomy."
        }, 
        "brief_title": "ENTegral Clinical Trial", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Total Laryngectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age more than or equal to 18 years old\n\n          -  Is indicated for total laryngectomy (first intention)\n\n          -  Must be able to comply with study requirements\n\n          -  Must be able to understand and be willing to provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Any condition that precludes the implantation of the ENTegral AL\n\n          -  Existing coagulation disorder\n\n          -  Contraindication for general anesthesia\n\n          -  Tumoral extension outside of the larynx invading through extra-laryngeal structures\n\n          -  Previous radiotherapy\n\n          -  Life-expectancy < 12 months\n\n          -  Be pregnant of breastfeeding or intention to becoming pregnant during study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948219", 
            "org_study_id": "LA-01-PEC-1"
        }, 
        "intervention": {
            "arm_group_label": "ENTegral Artificial Larynx implant", 
            "intervention_name": "ENTegral Artificial Larynx implant", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 18, 2013", 
        "location": {
            "contact": {
                "last_name": "George Lawson, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Yvoir", 
                    "country": "Belgium", 
                    "zip": "5530"
                }, 
                "name": "CHU Mont-Godinne"
            }, 
            "investigator": {
                "last_name": "George Lawson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Evaluation of the ENTegral Artificial Larynx (AL) in Patients Indicated for Total Laryngectomy", 
        "other_outcome": [
            {
                "description": "Quality of life using EORTC QLQ-C30 and QLQ-H&N25 questionnaires", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "1, 3, 6 months and 1 year"
            }, 
            {
                "description": "Number of patients with adverse events will be assessed at each follow-up during the 1 year patient follow-up", 
                "measure": "Number of patients with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Dyspnea evaluation using the Heyse-Moore scale at 1, 2, 3, 6, 9 months and 1 year", 
                "measure": "Dyspnea evolution", 
                "safety_issue": "No", 
                "time_frame": "1,2,3,6,9 months and 1 year"
            }, 
            {
                "description": "Patient phonation (able to talk and be understood, whispered voice) will be assessed at 1, 2, 3, 6, 9 months and 1 year", 
                "measure": "Phonation evolution", 
                "safety_issue": "No", 
                "time_frame": "1,2,3,6,9 months and 1 year"
            }, 
            {
                "description": "Implant use (manual closure of the tracheostomy orifice) duration will be assessed at 1, 2, 3, 6, 9 months and 1 year, allowing eventually to surgically close the orifice", 
                "measure": "Implant use", 
                "safety_issue": "No", 
                "time_frame": "1,2,3,6,9 months and 1 year"
            }
        ], 
        "overall_contact": {
            "email": "a.maniette@protipmedical.com", 
            "last_name": "Audrey Maniette"
        }, 
        "overall_contact_backup": {
            "email": "sophiehenryconsulting@gmail.com", 
            "last_name": "Sophie Henry"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of patients with adverse event associated with device implantation procedure", 
            "measure": "Feasibility of device implant procedure", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948219"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "ProTiP Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ProTiP Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}